Skip to content
healthcare.dev

Inon Ace

NDC 49873-402, magnesium aluminosilicates, magnesium hydroxide, simethicone, tablet, from Sato Pharmaceutical Co., Ltd..

Product NDC
49873-402
Status
Listed
Labeler
Sato Pharmaceutical Co., Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49873-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MAGNESIUM HYDROXIDE60 mg/1
  • SILODRATE200 mg/1
  • DIMETHICONE20 mg/1

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Skin Barrier Activity [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
49873-402-01498730402011 BOTTLE in 1 CARTON (49873-402-01) / 75 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49873-402 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49873-402 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49873-402. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.